The 2013 full year preliminary results for RSA Insurance Group plc was announced 27 February 2014.


"3 FOR 8 RIGHTS ISSUE AT 56 PENCE PER NEW ORDINARY SHARE
Further to the announcement on 27 February of its preliminary results for the year ended 31 December 2013, RSA Insurance Group plc ("RSA" or the “Company”) today announces the launch of a rights issue to raise £773 million in proceeds (£748 million net of expenses) (the “Rights Issue”). The Rights Issue is a fully underwritten 3 for 8 rights issue of 1,380,976,863 ordinary shares of 27.5 pence each in the capital of the Company at a price of 56 pence per New Ordinary Share.
The Issue Price of 56 pence per New Ordinary Share represents a discount of approximately 40% to the closing price of 93.4 pence on 24 March 2014 (being the last business day prior to the release of this announcement) and a 32.7% discount to the theoretical ex-rights price based on the closing price on 24 March 2014."

(thanks to skinny for this article)


Bottom chart 'fast stochastic'

So do I.

Opt,

I haven't got a clue of the "true" potential of any company in the market at the moment.

I am fairly certain that the analysts have the same problem as I do, but to slightly lesser degree,

I hold RSA and a few other high yielder and stopped myself from "churning" for another 6 - 12mths.

Probably wrong, but to keep on one's toes in a market as it is too difficult for me.

TA for me needs a relatively trending market.

Good luck.

Credit Suisse reiterates: 'Neutral' - TP unchanged: 125p.

JP Morgan Cazenove reiterates its Overweight TP unchanged @145p :-)

Half Yearly Report


Solid performance in a challenging environment

Net written premiums of £4.3bn, up by 4% at constant exchange (2% as reported)

Combined operating ratio (COR) of 95.2% with strong performances in Scandinavia and

Canada partially offset by adverse weather in the UK and earthquakes in Italy

Investment income of £267m and operating profit of £316m

IGD surplus of £1.2bn; coverage remains strong at 1.9 times

Upgraded by S&P to ‘A+’ (stable outlook) in February

Interim dividend up by 2% to 3.41p

Good progress on strategic priorities

Another excellent performance in Swedish Personal supported by improved profitability
in Denmark and Norway

Continued strong performance in Canada with double digit growth in Commercial led by
Large and Specialty. Acquisition of L’Union Canadienne will consolidate number 3 market position and bolster footprint in Quebec

Driving growth in UK Home, Pet and Specialty. UK Personal Motor premiums down by 19% as a result of ongoing management actions which deliver a sub-100% COR for the first time in four years
Emerging Markets again achieves double digit growth. Bolt-on acquisitions will position

RSA as a top 5 general insurer in Argentina; Czech operation closed as unable to achieve scale within a reasonable timeframe

Global Specialty lines grew by 6% at constant exchange and by 7% on an underlying basis

Continue to expect overseas operations to be c70% of Group premiums in 2015

Confident of delivering a good full year performance

Following adverse weather in the first half, now expect to deliver a COR for the Group
of better than 96%

Investment income still expected to be around £500m

12 month high today @117.50p

RSA

For me undervalued on forward forecasts and especially yield.

The gap was due to dividend grabbing.

The moving averages are short.

There was a hanging man during mornings dealings, based I think on 2 moderate size deals.

I believe there has been brokers upgrade to 125-130 but can't find it since reading. DYOH

Think SP worth 135.

Bought at 113.5

Year Ending Profit (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 414.48 11.67p 9.7 n/a -1.96% 9.41p 8.3%
31-Dec-13 485.94 13.68p 8.3 0.5 +17.24% 9.61p 8.5%

Fred - the hanging man is a bluff - unfortunately MAM charts quite often show these - today's low is (I believe) 112.6p

Agreed. It is intra-day and based on 2 deals.

My trading period is generally longer.

---------------------

Found notes

Target
28 Sep Exane BNP Paribas Outperform 112.35 133.00 133.00
27 Sep Daniel Stewart Buy 112.35 135.00 135.00
20 Sep Shore Capital Buy 112.35 - -
11 Sep Panmure Gordon Hold 112.35 110.00 110.00

Interim Management Statement

Premium growth1 in nine months to September 2012 of 4%.
Confirming guidance of combined operating ratio of better than 96% and investment income of around £500m for 2012.

Net written premium of £6.2bn representing growth of 4%1

Scandinavia up 2%1 to £1,403m

Canada up 6%1 to £1,179m

UK & Western Europe flat1 at £2,728m

Emerging Markets up 15%1 to £887m

IGD surplus remains strong at £1.2bn; coverage remains at 1.9 times. Economic capital surplus of £0.3bn

Net asset value (excluding IAS 19 pension deficit) up 1% to 105p per share

8 November: All reiterations:

Deutsche: Hold TP: 120p

Panmure Gordon: Hold TP: 110p

Investec Securities: Hold TP: 102p

RSA Group Announces Martin Scicluna as its New Chairman
Leading global insurer RSA today announces the appointment of Martin Scicluna as its new Chairman.

Martin brings considerable financial services experience having spent over 30 years at Deloitte where he was Chairman from 1995 to 2007. He has also built up wide Board experience in his current roles as Chairman of Great Portland Estates Plc and Chairman of the Audit committee and a Non-Executive Director of Lloyd’s Banking Group Plc.

He will join the Board on 1 January 2013 and succeeds John Napier who is stepping down after ten years with effect from 31 December 2012.
Edward Lea, Senior Independent Director, said:
“I am delighted that Martin is to be RSA’s next Chairman. His considerable knowledge and understanding of the financial services sector and his board experience will be real assets to the Group. Martin will bring a fresh approach that will support our aims to deliver an excellent service to our customers and value for our shareholders.

“I would also like to take this opportunity to thank John for his contribution and commitment to the company over the last ten years. Alongside the management team he has been instrumental in transforming RSA into the thriving global business it is today. The Board would like to congratulate John on his tenure as Chairman and wish him well for the future.”

Martin Scicluna said:
“It is a privilege to be appointed as Chairman of one of the world’s largest international insurers. I look forward to joining the RSA team and working with my new colleagues on the Board.”


Daniel Stewart Buy TP 135p Reiterates

Exane BNP Paribas Outperform TP 150.00p Reiterates

12 month high this morning @121.90p

12 month high today @123p.

Insurance cos enjoying a strong period Skinny, looking at your chart I see the RSI pushing 80..can pull back a bit from this high...but nothing can be certain.

Looking over bought again (like a lot of other shares) ho hum!

RSA

I put a little into sometime ago and bought a few SBs in last few days.

If you are interested, be careful as one broker dropped target, but I think it is worth 160p on Fundies and charts say the same to me.

But watch the double top formation.

Also ATR is 1 for stops, and OBV is 5 as it suits my trading.

Yield is not bad.


">





Not intentionally double posting!

Results tomorrow.

New highs today. I just hope the results live up to the heightened expectations.